MCRB - Seres Therapeutics Inc
9.32
0.190 2.039%
Share volume: 60,322
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$9.13
0.19
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-13-2024 | 11-13-2024 | 03-13-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | |
| Assets | ||||||||
| Total Assets | 341.262 M | 321.731 M | 178.742 M | 139.810 M | 164.182 M | 143.800 M | 143.473 M | |
| Current Assets | 165.181 M | 149.265 M | 72.928 M | 38.674 M | 66.078 M | 48.685 M | 51.527 M | |
| Inventories | 41.973 M | 52.997 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.418 M | 18.601 M | 0.000 | 0.000 | 0.000 | 0.000 | 426.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 111.184 M | 71.232 M | 66.824 M | 30.793 M | 58.849 M | 45.379 M | 47.638 M | |
| Total Non-current Assets | 1.401 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 19.115 M | 17.794 M | 12.566 M | 11.534 M | 10.547 M | 9.622 M | 8.578 M | |
| Other Assets | 156.966 M | 154.672 M | 93.248 M | 89.602 M | 87.557 M | 85.493 M | 83.368 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 341.262 M | 321.731 M | 178.742 M | 139.810 M | 164.182 M | 143.800 M | 143.473 M | |
| Total liabilities | 401.000 M | 408.805 M | 154.823 M | 126.026 M | 113.717 M | 110.850 M | 99.776 M | |
| Total current liabilities | 98.478 M | 108.282 M | 64.833 M | 41.222 M | 31.323 M | 30.940 M | 22.429 M | |
| Accounts Payable | 5.219 M | 4.809 M | 8.254 M | 4.079 M | 2.168 M | 2.200 M | 1.677 M | |
| Other liabilities | 105.149 M | 102.665 M | 89.990 M | 84.804 M | 82.394 M | 79.910 M | 77.347 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 102.009 M | 102.494 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 105.149 M | 102.665 M | 89.990 M | 84.804 M | 82.394 M | 79.910 M | 77.347 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -59.738 M | -87.074 M | 23.919 M | 13.784 M | 50.465 M | 32.950 M | 43.697 M | |
| Common stock | 958.630 M | 964.164 M | 986.381 M | 991.883 M | 995.882 M | 998.222 M | 1.001 B | |
| Retained earnings | -1.018 B | -1.051 B | -962.462 M | -978.099 M | -945.417 M | -965.272 M | -957.068 M |